NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression

Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion

(2012) Cynthia R Coffill et al.   EMBO REPORTS

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer

(2012) Magdalena Groblewska et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Cytokeratin 7 is a Predictive Marker for Survival in Patients with Esophageal Squamous Cell Carcinoma

(2011) Naohide Oue et al.   ANNALS OF SURGICAL ONCOLOGY

Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation

(2011) Lee-Yee Choong et al.   GENES CHROMOSOMES & CANCER

Histopathologic characteristics of early stage esophageal carcinoma: A comparative study with gastric carcinoma

(2010) Narihide Goseki et al.   CANCER

Outcome of Low-Volume Surgery for Esophageal Cancer in a High-Volume Referral Center

(2009) Ewout F. W. Courrech Staal et al.   ANNALS OF SURGICAL ONCOLOGY

Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma

(2009) Naoya Sakamoto et al.   CANCER SCIENCE

Ectodomain shedding of TNF-α is enhanced by nardilysin via activation of ADAM proteases

(2008) Yoshinori Hiraoka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS